
Richard D Granstein MD
George W. Hambrick, Jr. Professor of Dermatology. Dermatologist-in-Chief, NewYork-Presbyterian Hospital.
520 E 70th St# StarrNew York, NY 10021
Fax+1 212-746-8656
Overview of Dr. Granstein
Dr. Richard Granstein is a dermatologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 39 years. He is one of 286 doctors at New York-Presbyterian Hospital and one of 286 doctors at New York-Presbyterian Hospital who specialize in Dermatology. He has more than 100 publications and over 500 citings.
Education & Training
Boston Children’s HospitalMD, Immunology, 1982 - 1984
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1979 - 1983
NCI-Frederick Cancer Rersearch FacilityFellowship, 1981 - 1982
Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 1978 - 1979
David Geffen School of Medicine at UCLAClass of 1978
Certifications & Licensure
FL State Medical License 2021 - 2028
CA State Medical License 1979 - 2027
NJ State Medical License 2023 - 2027
NY State Medical License 1995 - 2027
MA State Medical License 1981 - 2026
MD State Medical License 1981 - 1994
American Board of Dermatology Dermatology
American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Rimegepant in Moderate Plaque-type Psoriasis Start of enrollment: 2021 Jan 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- IL-6 Signalling to Responding T Cells Is Key to Calcitonin Gene-Related Peptide-Exposed Endothelial Cell Enhancement of Th17 Immunity During Langerhans Cell Antigen Pr...Wanhong Ding, Cameron Moattari, Lori L Stohl, John A Wagner, Xi K Zhou
Immunology. 2025-04-01 - Neuroimmunology of psoriasis: Possible roles for calcitonin gene-related peptide in its pathogenesis.Joshua Kotlyar, Richard D Granstein
Brain, Behavior, & Immunity - Health. 2025-03-01 - 18 citationsProinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety.Emily L Keenan, Richard D Granstein
Acta Physiologica. 2025-03-01
Press Mentions
Biohaven Pharmaceuticals and Weill Cornell Medicine Collaborate to Initiate Proof of Concept Trial with CGRP Receptor Antagonist in Plaque PsoriasisNovember 16th, 2020
National Rosacea Society: New Grants Available in 2019December 19th, 2018
Rosacea Comorbidities and Future Research: The 2017 Update by the National Rosacea Society Expert CommitteeNovember 1st, 2017
Grant Support
- Langerhans Cells And Nerves: Bidirectional SignalingNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2009
- Vaccine Development: Purinergic Agonists As AdjuvantsNational Institute Of Allergy And Infectious Diseases2004–2005
- Sixth International Workshop On Langerhans CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999
- Langerhans Cells And Nerves--Bidirectional SignalingNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999
- Regulation Of Langerhans Cell FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–1999
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:







